Oncology Impact Fund (Cayman) Management L.P.

• CAMBRIDGE, MA How do I update this listing?

Oncology Impact Fund (cayman) Management is based out of Cambridge. Whalewisdom has at least 1 Form 4 filings The firm has no submitted 13F filings and does not appear to be an investment advisor.

Create Alert

Contact Info

oncology impact fund (cayman) management l.p.
450 KENDALL STREET
CAMBRIDGE MA 02142
Business Phone: 6174259200

SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Insider Information

Sunesis Pharmaceuticals Inc - >10% Owner (11/02/2017)
F-Star Therapeutics Inc - >10% Owner (03/25/2017)
TCR2 Therapeutics Inc - >10% Owner (02/19/2019)
Harpoon Therapeutics Inc - >10% Owner (04/09/2021)
Wells Fargo Money Market Fund-Class C - Other Owner (07/23/2020)
iTeos Therapeutics, Inc. - >10% Owner (04/09/2021)
ONCOR INC - >10% Owner (10/06/2020)
CONSOLIDATED GEMS INC COM STK (DE) - >10% Owner (01/12/2021)

Oncology Impact Fund (Cayman) Management L.P.

Contact Info

Insider Information

Recent SEC Filings

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Elevate your investments

Oncology Impact Fund (Cayman) Management L.P.

Email Notification.

Contact Info

Insider Information

Recent SEC Filings

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Elevate your investments